Detalhe da pesquisa
1.
Safety and efficacy of faldaprevir in combination with pegylated interferon α-2b and ribavirin in Japanese patients with genotype-1 chronic hepatitis C virus infection.
Hepatol Res
; 47(3): E142-E151, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153246
2.
Baseline hepatitis C virus (HCV) NS3 polymorphisms and their impact on treatment response in clinical studies of the HCV NS3 protease inhibitor faldaprevir.
Antimicrob Agents Chemother
; 58(2): 698-705, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24217701
3.
Molecular determinants and dynamics of hepatitis C virus secretion.
PLoS Pathog
; 8(1): e1002466, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22241992
4.
Viral resistance in hepatitis C virus genotype 1-infected patients receiving the NS3 protease inhibitor Faldaprevir (BI 201335) in a phase 1b multiple-rising-dose study.
Antimicrob Agents Chemother
; 57(10): 4928-36, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23877706
5.
Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C.
Antimicrob Agents Chemother
; 57(10): 4727-35, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23856779
6.
Dengue virus nonstructural protein 3 redistributes fatty acid synthase to sites of viral replication and increases cellular fatty acid synthesis.
Proc Natl Acad Sci U S A
; 107(40): 17345-50, 2010 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20855599
7.
Hepatitis C virus stimulates the phosphatidylinositol 4-kinase III alpha-dependent phosphatidylinositol 4-phosphate production that is essential for its replication.
J Virol
; 85(17): 8870-83, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21697487
8.
Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replication.
Proc Natl Acad Sci U S A
; 106(18): 7577-82, 2009 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19376974
9.
RNA interference and single particle tracking analysis of hepatitis C virus endocytosis.
PLoS Pathog
; 5(12): e1000702, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20041214
10.
Resistance Analyses of HCV NS3/4A Protease and NS5B Polymerase from Clinical Studies of Deleobuvir and Faldaprevir.
PLoS One
; 11(8): e0160668, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27494410
11.
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
Virology
; 476: 168-179, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25546252
12.
Possibilities for RNA interference in developing hepatitis C virus therapeutics.
Viruses
; 2(8): 1647-1665, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21994699
13.
Potential roles for cellular cofactors in hepatitis C virus replication complex formation.
Commun Integr Biol
; 2(6): 471-3, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20195453
14.
Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.
Virology
; 356(1-2): 68-78, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16945398
15.
Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.
Proc Natl Acad Sci U S A
; 101(7): 2094-9, 2004 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-14769917
16.
Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes.
Virology
; 301(2): 247-54, 2002 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-12359427